Berberine lowers blood glucose in type 2 diabetes, the receipts.
Multiple meta-analyses show effect sizes on fasting glucose and HbA1c comparable to metformin at 900 to 1,500 mg/day.
Strong evidence, per the methodology. Strongest 6 studies linked to PubMed.
Recommendation, contrary evidence, and dose are all on this page.
The studies
Strongest evidence, sourced.
Sorted by study tier (meta-analyses first, then RCTs, then reviews) and recency. Every entry links to PubMed by PMID.
At a glance
- Substances
- Berberine, Berberine HCl
- Evidence tier
- Strong evidence
- Strongest studies surfaced
- 6 of 9 matching
- One-line verdict
- Effective and underrated, but interaction-prone.
- Last verified
- May 30, 2026
Top 6 studies
-
Meta-analysis
Berberine improves metabolic profiles in type 2 diabetes
-
RCT
Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study) PMID 33024120
Berberine shifted gut microbiota composition, promoting beneficial bacteria while reducing harmful species; gut bacteria convert berberine into bioactive metabolites.
-
RCT
Efficacy of berberine in patients with type 2 diabetes mellitus PMID 18442638
Berberine activates AMPK and has glucose-lowering efficacy comparable to metformin in type 2 diabetes patients.
-
Review
Berberine and health outcomes: An umbrella review. PMID 36999891
An umbrella review confirmed berberine's benefits for glycemic control, lipid profiles, and blood pressure across multiple conditions with good safety profile.
-
Meta-analysis
-
Meta-analysis
Effects of administering berberine alone or in combination on type 2 diabetes mellitus: a systematic review and meta-analysis PMID 39640489
Contrary evidence
What pushes back.
Caveats, null findings, and methodological limits that hold the tier where it is.
What argues against the claim
- Most trials are Chinese and short (under 3 months).
- Frequent GI side effects (constipation, cramping) at full dose.
- Berberine inhibits CYP3A4: serious interaction risk with statins, immunosuppressants, anticoagulants.
Recommendation
What the evidence supports.
What we recommend, with caveats
500 mg, 2 to 3 times daily with meals. Not a replacement for metformin or other prescribed therapy. Coordinate with your physician if you take diabetes medication.
Tier criteria are documented at /methodology/evidence-tiers. Sourcing standards at /methodology/interactions.
Stack interaction risks
Where these substances clash.
Documented pairings involving the substances behind this claim. Cautions and conflicts come first.
Pairs in the database
- Berberine HCl + Cyclosporine/Tacrolimus · Contraindicated
- Berberine + Probiotics · Conflict
- Amlodipine + Berberine · Caution
- Atomoxetine + Berberine · Caution
- Atorvastatin + Berberine · Caution
- Berberine + Black Seed Oil · Caution
Open the free interaction checker at /interactions to scan a full routine.
Goal hubs
Where this claim feeds in.
Goal-based hubs that index this claim alongside related supplements and protocols.
Related goal hubs
Before you go
One claim, opened up. NutriStack does this for every claim in the database.
The full library lives at /research. Every entry follows the same shape: the verdict, the studies, the contrary evidence, the recommendation, and the primary literature.